Illumina and Nashville Biosciences expand Alliance for Genomic Discovery dataset to 312,000 whole genomes

Reuters03-05
<a href="https://laohu8.com/S/ILMN">Illumina</a> and Nashville Biosciences expand Alliance for Genomic Discovery dataset to 312,000 whole genomes

Illumina Inc. and Nashville Biosciences said the Alliance for Genomic Discovery expanded with the addition of Regeneron Genetics Center as its tenth member, increasing the core dataset to more than 312,000 whole genomes paired with longitudinal clinical data from de-identified electronic health records. The companies also announced a new multiomic initiative to add 50,000 additional whole genomes paired with proteomic data generated using Illumina Protein Prep, with GSK among the first participants in the expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603050915PR_NEWS_USPR_____LA02107) on March 05, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment